Home > Insider Trading > Filing (0001104659-17-017611)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1660719	Aralez Pharmaceuticals Inc.	ARLZ	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1184420	Seth Rudnick	C/O Aralez Pharmaceuticals Inc., 7100 West Credit Avenue, Suite 101 Mississauga A6 L5N 0E4		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares, Without Par Value	Acquisiton	2017-03-15	15,000	$2.26	79,391	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Shares, Without Par Value	30,000	Indirect	By Trust

Footnotes

This transaction was executed in two trades at prices of $2.21 and $2.37. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
These shares are held in the Seth A. Rudnick 2014 GST Trust U/A Dated 03/01/2014 (the "Trust") for the benefit of the Reporting Person's heirs. The Reporting Person's spouse is trustee of the Trust. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.